News • Interventional Unplanned PCI Rare After TAVI, but Operators Get Good Results In the first 2 years, PCI was mainly for ACS, but chronic disease with symptoms or ischemia was the leading indication thereafter. Michael O'Riordan January 18, 2021
Presentation TCT 2020 ILLUMENATE Trial Update:4-Year ILLUMENATE Global Stellarex DCB Data Presenter: Andrew Holden October 18, 2020
Presentation TCT 2020 IREMMI: Outcomes of MitraClip in Patients With Acute Mitral Regurgitation in AMI With and Without Cardiogenic Shock. IREMMI (International REgistry MitraClip in acute Myocardial Infarction) Presenter: Rodrigo Estévez-Loureiro October 17, 2020
Presentation TCT 2020 OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier Presenter: Dean J. Kereiakes October 17, 2020
Presentation TCT 2020 OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES Presenter: Dean Kereiakes October 17, 2020
Presentation TCT 2020 COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients Presenter: Robert Byrne October 17, 2020
News • Interventional Same Drop in MI, HF Admissions Seen in COVID-19’s Second Wave By Shelley Wood January 22, 2021
Feature Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers By Shelley Wood January 20, 2021
News • Interventional Unplanned PCI Rare After TAVI, but Operators Get Good Results By Michael O'Riordan January 18, 2021